Substance Use Disorder: Men vs. Women and Severity Levels

Key Takeaways

• Men have higher overall rates of substance use disorder, but women progress from initial use to dependence faster, a phenomenon researchers call “telescoping”
• Treatment barriers differ significantly by gender: women face childcare and stigma challenges; men face cultural reluctance to seek help
• DSM-5 classifies SUD severity as mild (2-3 criteria), moderate (4-5), or severe (6+), and severity directly determines appropriate treatment intensity
• Polysubstance use — using multiple substances concurrently — complicates treatment because each substance creates distinct medical risks and withdrawal profiles
• Gender-responsive treatment programs that address these differences show improved outcomes in clinical research

Substance use disorder does not affect everyone equally. Gender shapes the pattern of substance use, the speed at which dependence develops, the barriers to accessing treatment, and the clinical approaches most likely to succeed. Severity level, independently, determines how intensive treatment needs to be. This guide examines both dimensions to provide a clearer picture of how individual circumstances shape the path to recovery.

Gender Differences in Substance Use Disorder

Prevalence and Patterns

According to SAMHSA’s National Survey on Drug Use and Health (NSDUH), men are more likely than women to use most substances and to develop substance use disorders overall. However, the gender gap has been narrowing over the past two decades, particularly among younger age groups.

Factor	Men	Women
Overall SUD prevalence	Higher across most substances	Lower overall but increasing, especially in younger cohorts
Substances of concern	Higher rates of alcohol, cannabis, and stimulant use disorders	Higher rates of prescription opioid and sedative misuse; closing gap on alcohol
Motivation for initial use	More often sensation-seeking, social, or peer-influenced	More often emotional regulation, trauma response, or pain management
Route to treatment	More often through legal system referrals	More often through healthcare system or self-referral
Co-occurring conditions	Higher rates of antisocial personality, conduct disorder	Higher rates of PTSD, depression, anxiety, eating disorders

These patterns have direct clinical implications. A treatment program designed primarily around the male presentation of SUD may not address the trauma history, mood regulation challenges, and social circumstances that are more prevalent among women with the same diagnosis.

Telescoping: Faster Progression in Women

Telescoping refers to the observation that women tend to progress from first substance use to regular use, from regular use to dependence, and from dependence to treatment entry in a shorter timeframe than men. Research published in journals including Alcoholism: Clinical and Experimental Research has documented this pattern across multiple substances, including alcohol, opioids, and cannabis.

The clinical significance of telescoping is that women may present for treatment with a shorter use history but comparable or greater clinical severity. A woman with five years of alcohol use may have the same level of physical dependence and organ damage as a man with ten years of comparable consumption. This has implications for clinical assessment, where duration of use alone is an insufficient indicator of severity.

Treatment Barriers by Gender

Barriers Women Face

Women encounter specific obstacles in accessing addiction treatment that men generally do not:

Childcare responsibilities: Women with dependent children face practical barriers to entering residential treatment. Fear of child protective services involvement compounds this barrier. Programs that accommodate children or provide childcare support address a critical access gap, but such programs remain relatively uncommon.

Stigma: Social stigma around substance use is documented to be more severe for women than for men. Research in the Journal of Substance Abuse Treatment has found that women report higher levels of shame and are less likely to disclose substance use to healthcare providers.

Trauma history: Women in substance abuse treatment have higher rates of childhood sexual abuse, intimate partner violence, and other trauma exposure. Treatment programs that are not trauma-informed may inadvertently retraumatize women through confrontational approaches or mixed-gender group settings where trauma disclosure feels unsafe.

Physician referral gaps: Primary care physicians screen women for substance use disorders at lower rates than men, according to research from the National Institute on Alcohol Abuse and Alcoholism. This means women are less likely to be identified and referred to treatment through routine medical encounters.

Barriers Men Face

Men face different but equally significant obstacles:

Help-seeking reluctance: Socialized expectations around masculinity create resistance to acknowledging problems and seeking help. Men are more likely to view addiction as a character weakness rather than a medical condition, making them less likely to pursue treatment voluntarily.

Emotional engagement: Treatment modalities that emphasize emotional processing, group vulnerability, and interpersonal skill-building may encounter resistance from men socialized to avoid emotional expression. Programs that frame recovery in terms of skill-building and problem-solving may achieve better engagement.

Underrecognition of severity: Because male substance use is more socially normalized, men may go longer before their use is identified as problematic by family, employers, or healthcare providers.

Moderate vs. Severe Substance Use Disorder

DSM-5 Severity Classification

The DSM-5 diagnoses substance use disorder on a continuum based on how many of the 11 defined criteria a person meets within a 12-month period:

Severity	Criteria Met	Typical Presentation
Mild	2-3 of 11	Problematic use with some impairment; may maintain employment and relationships; early intervention can be effective
Moderate	4-5 of 11	Clear functional impairment; tolerance and early withdrawal signs may be present; structured treatment typically needed
Severe	6+ of 11	Significant impairment across multiple life domains; physical dependence common; residential treatment often indicated

The distinction between moderate and severe SUD is not merely academic. It determines the clinical pathway.

How Severity Guides Treatment Planning

ASAM (American Society of Addiction Medicine) criteria use a multidimensional assessment that incorporates DSM-5 severity alongside five other dimensions to determine appropriate level of care. In general:

• Mild SUD may be managed effectively with outpatient treatment (ASAM Level 1), brief interventions, or structured support programs
• Moderate SUD typically warrants intensive outpatient (Level 2.1) or partial hospitalization (Level 2.5) where structured, frequent clinical contact maintains accountability
• Severe SUD often requires residential treatment (Level 3.5 or higher), particularly when the individual’s recovery environment is unsupportive or when co-occurring medical or psychiatric conditions require stabilization

Insurance authorization is directly tied to documented severity. Clinicians who thoroughly document which of the 11 criteria are met, with specific behavioral examples, provide the strongest foundation for obtaining coverage for the clinically appropriate level of care.

Polysubstance Abuse: Using Multiple Substances

Common Polysubstance Combinations

Polysubstance use — the concurrent or sequential use of multiple substances — is more common than single-substance use disorders in clinical practice. According to NIDA, the majority of individuals entering treatment report using more than one substance. Common combinations include:

• Opioids and benzodiazepines: The combination responsible for the highest proportion of fatal overdoses, as both substances suppress respiratory function
• Cocaine and alcohol: When combined, the liver produces cocaethylene, a compound that amplifies cardiac toxicity and extends euphoria, reinforcing continued co-use
• Stimulants and opioids (“speedballing”): Alternating stimulants and opioids creates a cycle of stimulation and sedation that accelerates dependence on both
• Alcohol and prescription medications: Alcohol interacts dangerously with benzodiazepines, opioids, and many psychiatric medications

Why Polysubstance Use Complicates Treatment

Treating polysubstance use disorder is more clinically complex than treating a single-substance disorder for several reasons:

Multiple withdrawal syndromes: Each substance has a distinct withdrawal timeline and risk profile. Concurrent alcohol and benzodiazepine withdrawal creates compounded seizure risk. Opioid withdrawal layered over stimulant withdrawal involves simultaneous physical and psychological symptom management.

Medication interactions: Medication-assisted treatment options differ by substance. Buprenorphine addresses opioid dependence but does not treat alcohol or stimulant use disorders. Naltrexone addresses both opioid and alcohol use disorders but requires complete opioid abstinence before initiation.

Treatment planning complexity: A comprehensive treatment plan for polysubstance use must address each substance independently while recognizing that substances are often used in relationship to each other. Treating only the “primary” substance while ignoring secondary substances is associated with higher relapse rates.

Programs with experience managing polysubstance presentations, particularly those with addiction medicine physicians who can coordinate complex medication regimens, are better equipped for these cases.

Frequently Asked Questions

Do men and women respond differently to the same treatment? Research suggests that while core evidence-based treatments like CBT, motivational interviewing, and MAT are effective across genders, outcomes improve when treatment is adapted to address gender-specific factors. Women-only treatment groups, trauma-informed care protocols, and programs that address childcare barriers show improved retention and outcomes for women. For more on related population-specific considerations, see our page on substance use and pregnancy.

What is the difference between moderate and severe SUD in practical terms? The practical difference centers on functional impairment and treatment intensity. A person with moderate SUD may still maintain some daily functioning but is experiencing clear deterioration. A person with severe SUD typically has substantial impairment across work, relationships, health, and daily activities. Severe SUD usually requires more intensive and longer treatment.

Is polysubstance use more dangerous than single-substance use? Yes, in most clinical contexts. The combination of multiple substances creates compounded medical risks, more complex withdrawal presentations, and higher overdose risk. According to CDC data, the majority of overdose deaths involve more than one substance.

Should men and women be treated separately? Not necessarily for all components of treatment, but gender-specific group therapy sessions and programming can address barriers and issues that are difficult to discuss in mixed-gender settings. Many programs offer a combination of mixed-gender and gender-specific programming. For addiction statistics broken down by demographics, see our addiction statistics page.

---

This article is part of our guide to comparing addiction treatment concepts. For related reading on the diagnostic framework, see our comparison of substance use disorder vs. substance abuse. For information about which substances present the greatest recovery challenges, see hardest addictions to quit.

Last reviewed: March 2026.